SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-010314
Filing Date
2020-05-11
Accepted
2020-05-11 16:37:40
Documents
66
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20200331_10q.htm 10-Q 1253244
2 EXHIBIT 10.7 ex_185445.htm EX-10.7 8000
3 EXHIBIT 31.1 ex_184897.htm EX-31.1 9809
4 EXHIBIT 31.2 ex_184898.htm EX-31.2 9798
5 EXHIBIT 32.1 ex_184899.htm EX-32.1 6682
  Complete submission text file 0001437749-20-010314.txt   4974368

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20200331.xml EX-101.INS 949305
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20200331.xsd EX-101.SCH 55247
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20200331_cal.xml EX-101.CAL 39337
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20200331_def.xml EX-101.DEF 316209
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20200331_lab.xml EX-101.LAB 286783
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20200331_pre.xml EX-101.PRE 341340
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 20865462
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences